Cite
APA Citation
Jurczak, W., Rule, S., Townsend, W., Tucker, D., Sarholz, B., Scheele, J., Dyroff, M., Gribben, J. G., Długosz-Danecka, M., & Zinzani, P. L. (2021). phase I, first-in-human trial of Bruton's tyrosine kinase inhibitor M7583 in patients with B-cell malignancies. Leukemia & lymphoma, 62(10), 2392–2399. http://access.bl.uk/ark:/81055/vdc_100144745545.0x000040